LASA SUPERGENERICS
Back to Cashflow Statement
|
LASA SUPERGENERICS Last 5 Year Net Cash Inflow / Outflow History
[Standalone]
| Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹-0.19 Cr | ₹-10 Cr | ₹6.26 Cr | ₹1.27 Cr | ₹2.15 Cr |
What is the latest Net Cash Inflow / Outflow ratio of LASA SUPERGENERICS ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2024 | ₹-0.19 Cr |
| Mar2023 | ₹-10 Cr |
| Mar2022 | ₹6.26 Cr |
| Mar2021 | ₹1.27 Cr |
| Mar2020 | ₹2.15 Cr |
How is Net Cash Inflow / Outflow of LASA SUPERGENERICS Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2024 | ₹-0.19 Cr | Negative | |
| Mar2023 | ₹-10 Cr | Negative | |
| Mar2022 | ₹6.26 Cr | 392.83 | |
| Mar2021 | ₹1.27 Cr | -40.88 | |
| Mar2020 | ₹2.15 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of LASA SUPERGENERICS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LASA SUPERGENERICS | ₹39.5 Cr | 9.3% | -1% | -56.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹407,083.0 Cr | -1% | -7% | -1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹163,971.0 Cr | 5% | -2.7% | 15.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹140,660.0 Cr | 3.2% | -6.2% | 29.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,686.0 Cr | 2.3% | -8.1% | 13.5% | Stock Analytics | |
| CIPLA | ₹99,086.7 Cr | 0.9% | -7.8% | -12.5% | Stock Analytics | |
LASA SUPERGENERICS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LASA SUPERGENERICS | 9.3% |
-1% |
-56.3% |
| SENSEX | 4.7% |
-0.1% |
3.6% |
You may also like the below Video Courses